Oncology and the Affordable Care Act

Sanjiv S. Agarwala, MD

Video Categories: Affordable Care Act

Hear as Dr Agarwala deliberates the impact of the Affordable Care Act on oncology care.
July 13, 2021

Distinctions and Parallels Among TRK Inhibitors

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, explore the mutual and contrasting features of TRK inhibitors.

January 13, 2015

Benefits of Breast Cancer Index

Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.